ImmunoScape inks agreement with Cue Biopharma to launch next-gen cancer immunotherapy
The modular platform not only targets solid tumors but could also enhance traditional autologous and in vivo T cell therapies
The modular platform not only targets solid tumors but could also enhance traditional autologous and in vivo T cell therapies
Novartis is the only pharmaceutical company with a dedicated commercial RLT portfolio
The successful refinancing and enhancement of the syndicated credit facilities provides access to an additional CHF 40 million
Moraine will serve as OTSAW’s exclusive distributor in Japan, deploying the Camello+ autonomous mobile robot and TransCar autonomous guided vehicle to support hospital logistics
Dragon Copilot integrates generative AI, ambient listening, and natural language processing (NLP) to capture and document care directly
Agreements mark a major victory in the President’s long-term pledge to lower prescription drug costs for Americans
Enabling a new era in minimally invasive obesity treatment across Europe
Organic capex during the quarter amounted to Rs. 491.1 crore, supporting ongoing business expansion initiatives
The pharma giant's 11% rise in total revenue to $43.2 billion highlights consistent execution of its growth strategy
Subscribe To Our Newsletter & Stay Updated